This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on use of microbiome profiling for development of tests for women health. Innovations in the Synthetic Biology space, including advanced enzymatic DNA synthesis and engineered microbes for healthcare applications have been highlighted. Improvements in targeted drug delivery, and use of non invasive liquid biopsy for liver disease diagnosis has also been featured in this issue.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
GROWTH PIPELINE DIALOG™
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.